-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Scinai Immunotherapeutics Ltd. quarterly and annual Nonoperating Income (Expense) history and change rate from 2021 to 2024.
- Scinai Immunotherapeutics Ltd. Nonoperating Income (Expense) for the quarter ending 30 Jun 2023 was $-1,167,000, a 517% decline year-over-year.
- Scinai Immunotherapeutics Ltd. annual Nonoperating Income (Expense) for 2024 was $-1,325,000, a 141% decline from 2023.
- Scinai Immunotherapeutics Ltd. annual Nonoperating Income (Expense) for 2023 was $3,206,000, a 39.1% decline from 2022.
- Scinai Immunotherapeutics Ltd. annual Nonoperating Income (Expense) for 2022 was $5,265,000, a 98.2% increase from 2021.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)